Cargando…

Enhancement of Haloperidol Binding Affinity to Dopamine Receptor via Forming a Charge-Transfer Complex with Picric Acid and 7,7,8,8-Tetracyanoquinodimethane for Improvement of the Antipsychotic Efficacy

Haloperidol (HPL) is a typical antipsychotic drug used to treat acute psychotic conditions, delirium, and schizophrenia. Solid charge transfer (CT) products of HPL with 7,7,8,8-tetracyanoquinodimethane (TCNQ) and picric acid (PA) have not been reported till date. Therefore, we conducted this study t...

Descripción completa

Detalles Bibliográficos
Autores principales: Alamri, Abdulhakeem S., Alhomrani, Majid, Alsanie, Walaa F., Alyami, Hussain, Shakya, Sonam, Habeeballah, Hamza, Alamri, Abdulwahab, Alzahrani, Omar, Alzahrani, Ahmed S., Alkhatabi, Heba A., Felimban, Raed I., Alhabeeb, Abdulhameed Abdullah, Raafat, Bassem M., Refat, Moamen S., Gaber, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146347/
https://www.ncbi.nlm.nih.gov/pubmed/35630772
http://dx.doi.org/10.3390/molecules27103295
_version_ 1784716541408837632
author Alamri, Abdulhakeem S.
Alhomrani, Majid
Alsanie, Walaa F.
Alyami, Hussain
Shakya, Sonam
Habeeballah, Hamza
Alamri, Abdulwahab
Alzahrani, Omar
Alzahrani, Ahmed S.
Alkhatabi, Heba A.
Felimban, Raed I.
Alhabeeb, Abdulhameed Abdullah
Raafat, Bassem M.
Refat, Moamen S.
Gaber, Ahmed
author_facet Alamri, Abdulhakeem S.
Alhomrani, Majid
Alsanie, Walaa F.
Alyami, Hussain
Shakya, Sonam
Habeeballah, Hamza
Alamri, Abdulwahab
Alzahrani, Omar
Alzahrani, Ahmed S.
Alkhatabi, Heba A.
Felimban, Raed I.
Alhabeeb, Abdulhameed Abdullah
Raafat, Bassem M.
Refat, Moamen S.
Gaber, Ahmed
author_sort Alamri, Abdulhakeem S.
collection PubMed
description Haloperidol (HPL) is a typical antipsychotic drug used to treat acute psychotic conditions, delirium, and schizophrenia. Solid charge transfer (CT) products of HPL with 7,7,8,8-tetracyanoquinodimethane (TCNQ) and picric acid (PA) have not been reported till date. Therefore, we conducted this study to investigate the donor–acceptor CT interactions between HPL (donor) and TCNQ and PA (π-acceptors) in liquid and solid states. The complete spectroscopic and analytical analyses deduced that the stoichiometry of these synthesized complexes was 1:1 molar ratio. Molecular docking calculations were performed for HPL as a donor and the resulting CT complexes with TCNQ and PA as acceptors with two protein receptors, serotonin and dopamine, to study the comparative interactions among them, as they are important neurotransmitters that play a large role in mental health. A molecular dynamics simulation was ran for 100 ns with the output from AutoDock Vina to refine docking results and better examine the molecular processes of receptor–ligand interactions. When compared to the reactant donor, the CT complex [(HPL)(TCNQ)] interacted with serotonin and dopamine more efficiently than HPL only. CT complex [(HPL)(TCNQ)] with dopamine (CTtD) showed the greatest binding energy value among all. Additionally, CTtD complex established more a stable interaction with dopamine than HPL–dopamine.
format Online
Article
Text
id pubmed-9146347
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91463472022-05-29 Enhancement of Haloperidol Binding Affinity to Dopamine Receptor via Forming a Charge-Transfer Complex with Picric Acid and 7,7,8,8-Tetracyanoquinodimethane for Improvement of the Antipsychotic Efficacy Alamri, Abdulhakeem S. Alhomrani, Majid Alsanie, Walaa F. Alyami, Hussain Shakya, Sonam Habeeballah, Hamza Alamri, Abdulwahab Alzahrani, Omar Alzahrani, Ahmed S. Alkhatabi, Heba A. Felimban, Raed I. Alhabeeb, Abdulhameed Abdullah Raafat, Bassem M. Refat, Moamen S. Gaber, Ahmed Molecules Article Haloperidol (HPL) is a typical antipsychotic drug used to treat acute psychotic conditions, delirium, and schizophrenia. Solid charge transfer (CT) products of HPL with 7,7,8,8-tetracyanoquinodimethane (TCNQ) and picric acid (PA) have not been reported till date. Therefore, we conducted this study to investigate the donor–acceptor CT interactions between HPL (donor) and TCNQ and PA (π-acceptors) in liquid and solid states. The complete spectroscopic and analytical analyses deduced that the stoichiometry of these synthesized complexes was 1:1 molar ratio. Molecular docking calculations were performed for HPL as a donor and the resulting CT complexes with TCNQ and PA as acceptors with two protein receptors, serotonin and dopamine, to study the comparative interactions among them, as they are important neurotransmitters that play a large role in mental health. A molecular dynamics simulation was ran for 100 ns with the output from AutoDock Vina to refine docking results and better examine the molecular processes of receptor–ligand interactions. When compared to the reactant donor, the CT complex [(HPL)(TCNQ)] interacted with serotonin and dopamine more efficiently than HPL only. CT complex [(HPL)(TCNQ)] with dopamine (CTtD) showed the greatest binding energy value among all. Additionally, CTtD complex established more a stable interaction with dopamine than HPL–dopamine. MDPI 2022-05-20 /pmc/articles/PMC9146347/ /pubmed/35630772 http://dx.doi.org/10.3390/molecules27103295 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Alamri, Abdulhakeem S.
Alhomrani, Majid
Alsanie, Walaa F.
Alyami, Hussain
Shakya, Sonam
Habeeballah, Hamza
Alamri, Abdulwahab
Alzahrani, Omar
Alzahrani, Ahmed S.
Alkhatabi, Heba A.
Felimban, Raed I.
Alhabeeb, Abdulhameed Abdullah
Raafat, Bassem M.
Refat, Moamen S.
Gaber, Ahmed
Enhancement of Haloperidol Binding Affinity to Dopamine Receptor via Forming a Charge-Transfer Complex with Picric Acid and 7,7,8,8-Tetracyanoquinodimethane for Improvement of the Antipsychotic Efficacy
title Enhancement of Haloperidol Binding Affinity to Dopamine Receptor via Forming a Charge-Transfer Complex with Picric Acid and 7,7,8,8-Tetracyanoquinodimethane for Improvement of the Antipsychotic Efficacy
title_full Enhancement of Haloperidol Binding Affinity to Dopamine Receptor via Forming a Charge-Transfer Complex with Picric Acid and 7,7,8,8-Tetracyanoquinodimethane for Improvement of the Antipsychotic Efficacy
title_fullStr Enhancement of Haloperidol Binding Affinity to Dopamine Receptor via Forming a Charge-Transfer Complex with Picric Acid and 7,7,8,8-Tetracyanoquinodimethane for Improvement of the Antipsychotic Efficacy
title_full_unstemmed Enhancement of Haloperidol Binding Affinity to Dopamine Receptor via Forming a Charge-Transfer Complex with Picric Acid and 7,7,8,8-Tetracyanoquinodimethane for Improvement of the Antipsychotic Efficacy
title_short Enhancement of Haloperidol Binding Affinity to Dopamine Receptor via Forming a Charge-Transfer Complex with Picric Acid and 7,7,8,8-Tetracyanoquinodimethane for Improvement of the Antipsychotic Efficacy
title_sort enhancement of haloperidol binding affinity to dopamine receptor via forming a charge-transfer complex with picric acid and 7,7,8,8-tetracyanoquinodimethane for improvement of the antipsychotic efficacy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146347/
https://www.ncbi.nlm.nih.gov/pubmed/35630772
http://dx.doi.org/10.3390/molecules27103295
work_keys_str_mv AT alamriabdulhakeems enhancementofhaloperidolbindingaffinitytodopaminereceptorviaformingachargetransfercomplexwithpicricacidand7788tetracyanoquinodimethaneforimprovementoftheantipsychoticefficacy
AT alhomranimajid enhancementofhaloperidolbindingaffinitytodopaminereceptorviaformingachargetransfercomplexwithpicricacidand7788tetracyanoquinodimethaneforimprovementoftheantipsychoticefficacy
AT alsaniewalaaf enhancementofhaloperidolbindingaffinitytodopaminereceptorviaformingachargetransfercomplexwithpicricacidand7788tetracyanoquinodimethaneforimprovementoftheantipsychoticefficacy
AT alyamihussain enhancementofhaloperidolbindingaffinitytodopaminereceptorviaformingachargetransfercomplexwithpicricacidand7788tetracyanoquinodimethaneforimprovementoftheantipsychoticefficacy
AT shakyasonam enhancementofhaloperidolbindingaffinitytodopaminereceptorviaformingachargetransfercomplexwithpicricacidand7788tetracyanoquinodimethaneforimprovementoftheantipsychoticefficacy
AT habeeballahhamza enhancementofhaloperidolbindingaffinitytodopaminereceptorviaformingachargetransfercomplexwithpicricacidand7788tetracyanoquinodimethaneforimprovementoftheantipsychoticefficacy
AT alamriabdulwahab enhancementofhaloperidolbindingaffinitytodopaminereceptorviaformingachargetransfercomplexwithpicricacidand7788tetracyanoquinodimethaneforimprovementoftheantipsychoticefficacy
AT alzahraniomar enhancementofhaloperidolbindingaffinitytodopaminereceptorviaformingachargetransfercomplexwithpicricacidand7788tetracyanoquinodimethaneforimprovementoftheantipsychoticefficacy
AT alzahraniahmeds enhancementofhaloperidolbindingaffinitytodopaminereceptorviaformingachargetransfercomplexwithpicricacidand7788tetracyanoquinodimethaneforimprovementoftheantipsychoticefficacy
AT alkhatabihebaa enhancementofhaloperidolbindingaffinitytodopaminereceptorviaformingachargetransfercomplexwithpicricacidand7788tetracyanoquinodimethaneforimprovementoftheantipsychoticefficacy
AT felimbanraedi enhancementofhaloperidolbindingaffinitytodopaminereceptorviaformingachargetransfercomplexwithpicricacidand7788tetracyanoquinodimethaneforimprovementoftheantipsychoticefficacy
AT alhabeebabdulhameedabdullah enhancementofhaloperidolbindingaffinitytodopaminereceptorviaformingachargetransfercomplexwithpicricacidand7788tetracyanoquinodimethaneforimprovementoftheantipsychoticefficacy
AT raafatbassemm enhancementofhaloperidolbindingaffinitytodopaminereceptorviaformingachargetransfercomplexwithpicricacidand7788tetracyanoquinodimethaneforimprovementoftheantipsychoticefficacy
AT refatmoamens enhancementofhaloperidolbindingaffinitytodopaminereceptorviaformingachargetransfercomplexwithpicricacidand7788tetracyanoquinodimethaneforimprovementoftheantipsychoticefficacy
AT gaberahmed enhancementofhaloperidolbindingaffinitytodopaminereceptorviaformingachargetransfercomplexwithpicricacidand7788tetracyanoquinodimethaneforimprovementoftheantipsychoticefficacy